Recombinant CD70 (Cusatuzumab Biosimilar) antibody

Catalog No. ABIN7597609

The Humanized Chimeric anti-CD70 (Cusatuzumab Biosimilar) antibody has been validated for not_set. It is suitable to detect CD70 (Cusatuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD70 (Cusatuzumab Biosimilar) antibody (ABIN7597609)

Target: CD70 (Cusatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD70 (Cusatuzumab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-CD70 (Cusatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Cusatuzumab Biosimilar Antibody

Specificity: CD27 ligand, CD70, TNFSF7, CD27LG, CD27L, CD70 antigen, Tumor necrosis factor ligand superfamily member 7, CD27-L

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 lambda

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD70 (Cusatuzumab Biosimilar)

Target: CD70 (Cusatuzumab Biosimilar)

Alternative Name: Cusatuzumab Biosimilar

Target Type: Biosimilar

Background: CD27 ligand, CD70, TNFSF7, CD27LG, CD27L, CD70 antigen, Tumor necrosis factor ligand superfamily member 7, CD27-L

UniProt: P32970

CAS-No: 1399546-01-0